WWW.ISPESINGAPORE.ORG

Technology Innovations, Improving Healthcare10 - 12 December 2020 I Suntec Singapore & Online

ISPE Singapore Affiliate’s 2020 Conference and exhibition will be a hybrid eventCombining a live, in-person experience with immersive virtual broadcasting and networking, ISPE Singapore affiliate’s 2020 gathering will be accessible to pharma industry stakeholders globally.

1000+PARTICIPANTS

65+SPEAKERS

25+COUNTRIES

3DAYS

CONFERENCE AND EXHIBITION

QUALITY & COMPLIANCE

COVID-19 MARKET SCENARIOS

INDUSTRY-REGULATOR

COLLABORATION

DATA INTEGRITY & GAMP

TECHNOLOGY DEVELOPMENT IN MANUFACTURING

INNOVATIONS IN DIGITAL PHARMA

REGULATORY AND COMPLIANCE

POST CONFERENCE:

BEST PRACTICES & TECHNOLOGY

SYMPOSIUMTOPICS COVERED IN 2020

DELIVERED ONSITE &

ONLINE

Organised by:

WWW.ISPESINGAPORE.ORG

CONFERENCE AND EXHIBITION

AGENDA AT A GLANCE:

NEW FORMATS & COVID-19 ADVISORY

MAIN CONFERENCE DAY 1 - 10 DECEMBER

MAIN CONFERENCE DAY 2 - 11 DECEMBER

WOMEN IN PHARMA ROUNDTABLE LUNCH

OPENING PLENARY SESSIONS:SINGAPORE EDB’S KEYNOTE: The Impact of COVID-19 on Government Investments & Partnerships in Healthcare Innovation

REGULATOR’S KEYNOTE: PIC/s Inspection Reliance and Desktop Inspections

PANEL DISCUSSION: Pandemic Crisis Response: Ensuring the Cure Isn’t Worse than the Disease

REGULATORY & COMPLIANCE SESSIONS

PHARMANITE & HACKATHON WINNERS PRESENTATION

INNOVATIONS IN DIGITAL PHARMA TRACK SESSIONS

PHARMA MANUFACTURING SESSIONS

PLANNING & EXECUTING A SUCCESSFUL PROJECT

TECH DEVELOPMENTS IN MANUFACTURING SESSIONS

YOUNG PROFESSIONALS’ NETWORKING

POST-CONFERENCE: BEST PRACTICES / TECHNOLOGY SYMPOSIUM – 12 DECEMBER*AVAILABLE ONLINE AND FREE FOR ALL REGISTERED ATTENDEES

COVID-19 PRECAUTIONS & YOUR SAFETY:

The safety of all our participants is of utmost importance, and this decision has been taken after

reassuring ourselves of biosafety measures that will be in place at the venue. We continue to monitor travel advisories and will implement local regulations and

industry guidelines onsite.

THE FACE-2-FACE & VIRTUAL PROGRAMME:

This year the ISPE Singapore affiliate Conference will be both physical and virtual. You will experience a high-quality live stream of the physical event, that

promises all the content as well as virtual networking options. Join and interact in live discussions, catch up on sessions you missed or watch again after the event.

NEW CONTENT:Take part in our series of digital theatres in the lead

up to the main event, with on-demand content available up to 3 months after the conference. All this,

alongside a repurposed programme with COVID-19 market scenarios and over 40 manufacturer speakers

from 15 countries.

WWW.ISPESINGAPORE.ORG

David Churchward Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector) MHRA, UK

Chong Hock Sia Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group Health Sciences Authority, Singapore

Sook Peng Chua ASEAN Regulatory and Quality Compliance Director Johnson and Johnson (J&J), Singapore

Anchalee Anuchitanukul Head of Compliance, Pharmaceuticals, Country Compliance Head Novartis, Thailand

Pakhi Rusia Director of Global Regulatory Affairs GSK, Singapore

Ewelina Markuszewska Quality Control Expert DaviPharm (Adamed Group), Vietnam

Lam Quang Nhat Quality Assurance, Pharmacovigilance, Regulatory Affairs Executive Daiichi Sankyo Co., Ltd., Vietnam

Hazem Eleskandarani Project Director, Engineering & Property Services Johnson & Johnson, United States

Dr. Faseeh Abdus Salam Production Head FAAS Pharmaceutical Pte. Ltd., Pakistan

Dasarathi KKC Head of Regulatory Affairs (API) Aurobindo Pharma, India

Roger Harty Director of EMEA & APAC AstraZeneca, Belgium

Samme Wang Head of Engineering and Technology Asia Bayer, Singapore

James Wu Chief IT Officer Roche, Taiwan

Rajnish Narula Director Business Excellence Pfizer, Singapore

Rajesh Thempadiyil Business Process Excellence & CoE Lead Dr. Reddy’s Laboratories Ltd., India

Ahmed Abdel Rahman Bashtar Regional QA Compliance Head Julphar, United Arab Emirates

Meidi Fransisca Siregar IT Manufacturing Lead PT Bayer Indonesia

Ewan Dowie Head of Production Ego Pharmaceuticals, Australia

Raneeth Reghu Head of Procurement Biocon Biologics, Malaysia

Minh Tran Chief Operating Officer Stelis Biopharma, India

Dr. Anthony Deodaunia William Senior Manager Technical Operations- API Manufacturing AbbVie, Singapore

Shailendra Singh Bhadoria Head- Manufacturing and Sciences Oncogen Pharma, Malaysia

Md. Zakar Executive Director, Plant Operations NIPRO JMI Pharma Ltd., Bangladesh

Ahmad Fikri Hasim Head of Production Ain Medicare Sdn Bhd, Malaysia

Taufik Muhammad Engineering Compliance Expert Novartis, Singapore

STELLAR LINE-UP OF GLOBAL PHARMA MANUFACTURERS AND EXPERTS

SPONSORS AND EXHIBITORSAssociate Sponsor Networking

Cocktail SponsorSponsorTrack Sponsor Exhibitors

17:45 PharmaNite & Hackathon Winners Presentation

WWW.ISPESINGAPORE.ORG

THURSDAY, 10 DECEMBER 2020: MAIN CONFERENCE DAY 1

10:45 Opening of ISPE Singapore Exhibition & Morning Refreshments

NEW! Power Hour Presentations at the Exhibition Hall

13:00 Networking Lunch & Speaker Roundtables

16:00 Afternoon Networking & Refreshment Break

08:00 Main Conference Registration & Morning Coffee

09:00 Welcome RemarksShanshan Liu, President, ISPE Singapore Affiliate

09:10 Opening AddressFran Zipp, International Board Chair, ISPE, & Chief Executive Officer, Lachman Consultant Services, United States

09:20 The Impact of COVID-19 on Government Investments & Partnerships in Healthcare InnovationSenior Representative from Singapore’s Economic Development Board

09:30 REGULATOR KEYNOTE: PIC/s Inspection Reliance and Desktop Inspections Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland

10:00 PLENARY PANEL DISCUSSION: Pandemic Crisis Response: Ensuring the Cure Isn’t Worse than the Disease• Drug shortages• Regulating for expedited trials and approvals • Balancing ethical processes vs speed to market • Maintaining risk and compliance while scaling agile• COVID 19: Lessons learned in effective global co-operation in times of crisis

Chairperson: Pierre Winnepenninckx, Conference Chair, ISPE Singapore Affiliate

REGULATORY & COMPLIANCE Chairperson: Robert Tribe, Asia-Pacific Regulatory Affairs Advisor, ISPE

REGULATORY & COMPLIANCE Chairperson: Fran Zipp, International Board Chair, ISPE, & Chief Executive Officer, Lachman Consultant Services, United States

11.30 Brexit UpdateDavid Churchward, Deputy Unit Manager, Inspectorate Strategy andInnovation (Expert GMP Inspector), MHRA, UK

11:45 ASEAN MRA Update• Future ASEAN developments on pharmaceutical inspections• Singapore’s partnerships in MRAs and reliance in pharmaceutical

inspection and regulationChong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore

12.00 Update on ICH-Q13Dr Yoshihiro Matsuda, Senior Scientist (for Quality) PMDA, & Regulatory Chair, ICH-Q13, Japan

12:15 PANEL DISCUSSION: Industry-Regulator Collaboration• Training• Regulatory document reviews• Identification of emerging problemsModerator: Vasiliki (Vee) Revithi, Ex-Head, GMDP Inspectorate, EOF Medicines Agency of Greece

16:30 Myanmar Pharma Industry View on ASEAN GMP• Updates on ASEAN MRA on GMP• Compliance with ASEAN GMP• Meeting data integrity requirements in MyanmarChandrakant Bhandare, Head of Quality, Zydus Cadila Myanmar

16:45 Implementing and Complying with International cGMPs in Pakistan’s Pharma Industry• Overview of regulatory framework and national pharma manufacturing

industry in Pakistan• Major challenges confronting the industry• Importance of cGMP to combat quality issues in pharma:

o Identity, quality, strength & purity of drugo Proper design, monitoring and control on manufacturing process and

facilitiesDr. Faseeh Abdus Salam, Production Head, FAAS Pharmaceutical Pte. Ltd., Pakistan

17:00 Changing Regulatory Landscape and Current Challenges for the API Industry• Areas of regulatory changes from past years to recent• New trends in regulatory enforcement in life sciences• New requirements to reduce audit compliance risk in the current scenario• Regulatory compliance through real data managementDasarathi KKC, Head of Regulatory Affairs (API), Aurobindo Pharma, India

17:15 PANEL DISCUSSION: Regulatory Compliance in Emerging MarketsModerator:Alfonsus Karli, APAC GCMC Advisory Office Director, Pfizer Pte Ltd & ISPE Singapore affiliate Vice Chair, Regulatory AffairsPanellists:Anchalee Anuchitanukul, Head of Compliance, Pharmaceuticals, Country Compliance Head, Novartis, Thailand

Chandrakant Bhandare, Head of Quality, Zydus Cadila MyanmarEwelina Markuszewska, Quality Control Expert, DaviPharm (Adamed Group), VietnamChong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore More speakers to be confirmed.

15:00 Compliance Monitoring: A Health Check-Up Tool and its Importance• What is compliance monitoring and why is it crucial?• Challenges & techniques to improve monitoring to anticipate and mitigate

compliance riskAnchalee Anuchitanukul, Head of Compliance, Pharmaceuticals, Country Compliance Head, Novartis, Thailand

15:15 Quality by Design during Product Development & BeyondPakhi Rusia, Director of Global Regulatory Affairs, GSK, Singapore

15:30 Transitioning of EU GMP and Adapting Entry into Emerging Markets• Some regulatory characteristics of the Vietnamese Drug Administration

(DAV)• How harmonized are the different international standards on drug

production (ASEAN GMP, WHO GMP, EU GMP)?• Compliance and data integrity challenges in Vietnam, and lessons learntEwelina Markuszewska, Quality Control Expert, DaviPharm (Adamed Group), Vietnam

15:45 Managing Regulatory Compliance in Vietnamese Pharma Market• Impact of the new Decree 155 on regulatory compliance• Considerations to align your Big Pharma regulatory strategy to the local market • Inspection Readiness: what to expect and how to prepareLam Quang Nhat, Quality Assurance, Pharmacovigilance, Regulatory Affairs Executive, Daiichi Sankyo Co. Ltd., Vietnam

Moderator:Robert Tribe, Asia-Pacific Regulatory Affairs Advisor, ISPEPanellists:David Churchward, Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector), MHRA, UKDr Yoshihiro Matsuda, Senior Scientist (for Quality) PMDA, & Regulatory Chair, ICH-Q13, JapanAnne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland

Panellists:Sook Peng Chua, ASEAN Regulatory and Quality Compliance Director, Johnson and Johnson (J&J), SingaporeChong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, SingaporeDr. Georg Singewald, Global Quality Control, Vice President, Roche, SwitzerlandAnne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland

WWW.ISPESINGAPORE.ORG

FRIDAY, 11 DECEMBER 2020: MAIN CONFERENCE DAY 2

17:45 End of Main Conference

15:30 Afternoon Networking & Refreshment Break

18:00 Young Professionals’ Networking @ Paulaner Bräuhaus Singapore

12:30 Networking Lunch & Women in Pharma Roundtables Lunch

10:15 Morning Networking & Refreshment Break

09:00 KEYNOTE ADDRESS: Embracing the Digital Pharma Factory of Tomorrow• AstraZeneca’s current digital factories initiative strategy• How the factories of the future will bring about change• How to successfully imbed this change in the organizational cultureRoger Harty, Director of EMEA & APAC, AstraZeneca, Belgium

09:30 PANEL DISCUSSION: Reaching Digital Maturity through Pharma 4.0• Applying Big Data, information systems and digital tech in pharma

manufacturing• Life cycle management for organisation and process• Major issues and success factors facing digital transformation • Communication and decision making driving cultural change

Moderator: Pierre Winnepenninckx, Conference Chair, ISPE Singapore Affiliate & Chief Executive Officer, No Deviation Pte. Ltd. Panellists:Roger Harty, Director of EMEA & APAC, AstraZeneca, BelgiumJames Wu, Chief IT Officer, Roche, Taiwan Samme Wang, Head of Engineering and Technology Asia, Bayer, Singapore Rajnish Narula, Director Business Excellence, Pfizer, Singapore

10.45 Significance of Digitalisation in Operations and Usage of Pharma 4.0 for Accelerating the Same• What we learned from lock down conditions• Business Continuity Plan during COVID 19 • Change in operations strategy after COVID19Rajesh Thempadiyil, Business Process Excellence & CoE Lead, Dr. Reddy’s Laboratories Ltd., India

11:00 Technologies Reshaping the Future of the Pharma Industry• History of the tech revolution and its link to the pharma industry• Remaining barriers to tackle• Top technological approaches to use in pharma• Examples of newly-applied tech in therapies like personalised medicine

Ahmed Abdel Rahman Bashtar, Regional QA Compliance Head, Julphar, United Arab Emirates

11:15 Technology Innovation for the FutureJames Wu, Chief IT Officer, Roche, Taiwan

11:30 State of IT Security in Pharma Manufacturing• Background of pharma manufacturing IT security• Pharma industry risks and treats• Industry trends and their impact on security• Gaps analyses and best practicesMeidi Fransisca Siregar, IT Manufacturing Lead, PT Bayer Indonesia

11:45 Developing a Robust Quality System to Assure Data Integrity• Regulatory trends and guidance in Philippines’ pharma industry• How data integrity and process monitoring are critical to each other for

regulatory compliance• Link between data integrity and quality culture• Remaining pain-points in data integrityCloyd Lambojon, Supervisor Production / Site Data Integrity Lead, GSK, Philippines

12.00 Leadership, Lean Manufacturing and Pharma 4.0Ewan Dowie, Head of Production, Ego Pharmaceuticals, Australia

12.15 Open Q&A for session speakers

INNOVATIONS IN DIGITAL PHARMA

TECHNOLOGY DEVELOPMENTS IN MANUFACTURING

13.30 Designing a CMC Strategy for Accelerated Development of Biotherapeutics* Keqiang (Peter) Shen, Vice President, Head of MFG3, Clinical Manufacturing, WuXi Biologics, China*

13.45 The Role of Design of Experiments in the Product Lifecycle Management • Product Lifecycle management fundamentals and stages of product

realization• Key elements of quality by design (QbD)• Design of Experiment as a powerful technique of QbD & Process

Optimization• Practical considerations for implementing compression profiling & Design

of Experiment for Oral Solid Dosage FormsAlfonso Quiros, New Product Introduction & Technical Head, Site Leadership Team Kuala Lumpur, CHSC Asia Pacific, GSK, Malaysia

14.00 Sourcing Challenges and Imperatives in the Biologics Space• Current state of end-end manufacturing processes for biologics• Challenges specific to manufacturing biologics • Best practices in vendor managementRaneeth Reghu, Head of Procurement, Biocon Biologics, Malaysia

14:15 CASE STUDY: Lean CapEx Project Delivery to Support Patients in Asia-Pacific• Importance of capital-expenditure management in pharma• How does lean help to maximize CapEx benefits and patient-centricity?• Project Management team:o Project methodologyo Externalisationo Talent developmentSamme Wang, Head of Engineering and Technology Asia, Bayer, Singapore

14.30 Isolators for Pharmaceutical ManufacturingShailendra Singh Bhadoria, Head- Manufacturing and Sciences, Oncogen Pharma (Malaysia)

14:45 Cleaning Validation & Verification Case Study:From Initial Tech Transfer from API to Commercial Manufacturing Dr. Anthony Deodaunia William, Senior Manager Technical Operations- API Manufacturing, AbbVie, Singapore

15:00 Key Considerations for Successful Implementation of Single Use Systems in Final Filling of Drug Products Minh Tran, Chief Operating Officer, Stelis Biopharma, India

15:15 Open Q&A for session speakers

16:00 Time for Integrating Excellence Models in Pharma• Visual management• Data-driven performance management• Systematic process for generating and implementing continuous improvementsRajnish Narula, Director Business Excellence, Pfizer, Singapore

16:15 Statistical Techniques for Product Quality Improvement & Monitoring• Importance of applying statistical thinking to quality improvement• Overview of practical and simply statistical methods used for quality

improvement• Practical and statistical considerations when choosing a statistical method

to useMd. Zakar, Executive Director, Plant Operations, NIPRO JMI Pharma Ltd., Bangladesh

16:30 Basic Considerations and Implementation of Track and Trace in Pharma Manufacturing• Regulatory environment and global requirements• Benefits of track and trace system to the pharma industry• Key elements of a successful track and trace system• Challenges in implementing track and trace technologyAhmad Fikri Hasim, Head of Production, Ain Medicare Sdn Bhd, Malaysia

16:45 Improving Energy Efficiency in Pharmaceutical ManufacturingTaufik Muhammad, Engineering Compliance Expert, Novartis, Singapore

17:00 PANEL DISCUSSION: Lean Manufacturing Operations – Achieving More with Less• Strategies to achieving pharma operational excellence• Best practices to optimise flexible and agile production`• Reducing waste, maximising productivity

Moderator:Hazem Eleskandarani, Project Director, Engineering & Property Services, Johnson & Johnson, USAPanellists:Minh Tran, Chief Operating Officer, Stelis Biopharma, India Dr. Anthony Deodaunia William, Senior Manager Technical Operations - API Manufacturing, AbbVie, SingaporeMeidi Fransisca Siregar, IT Manufacturing Lead, PT Bayer Indonesia Ahmad Fikri Hasim, Head of Production, Ain Medicare Sdn Bhd, Malaysia Keqiang (Peter) Shen, Vice President, Head of MFG3, Clinical Manufacturing, WuXi Biologics, China*

SATURDAY 12 DECEMBER 2020: POST-CONFERENCE: BEST PRACTICES / TECHNOLOGY SYMPOSIUM

Available online & free for all registered attendees

10:30 Morning Tea & Networking Break

08:30 Registration

09.00 Flexible and Smart Production of Tomorrow’s Medicines The healthcare sector is facing tremendous changes • Novel Cell & Gene Therapies such as CAR-T conquer the market • Pharmaceutic production methods change radically • Flexible plants for prudent CAPEX decisionsDr. Stefan Kappeler, Technology Manager Life Sciences, Exyte, Switzerland

09:15 Building the External Supplier Relationship: Ensuring a Safe and Productive Supply Chain• Compliance expectations for both the MAH Holder and the CMO/Lab• Quality Agreements – what they need to include • Supply Agreements – how they can aid the relationship• MAH oversight and staffing needs – many companies understaffBeth Haas, Principal Consultant / Senior Project Manager, CAI, USA

09.30 Regulatory compliance - CMC perspective Vijay Mardane, Regulatory CMC Manager APAC, Abbott Laboratories, Singapore

09.45 High Containment using Single Use Systems for HPAPI Manufacturing

11.00 Re-thinking Business Resiliency in Life Sciences 4.0Cyber-attacks or the threat of disruption to production are happening more frequently than ever. Business Agility has been challenged under such circumstances and it’s critical to put in place resiliency frameworks/technologies to recover business service, especially where companies strive to avoid a disruption in their supply to the market.Joint Presentation:Claire Tran, Project Manager, Zenith, SingaporeLay Peng Tan, IT Manager, AbbVie Singapore Manufacturing

11.15 Data Integrity Compliance and Key to Reduce Data Integrity Violation TrendsShantha Kumara, Quality Assurance Manager, Strides Pharma, Singapore

11.30 Digitisation for Data Integrity: Collect, Connect & Contextualise Quality and Production Data• Key obstacles to plant automation • Using digital tech to integrate quality and production • Importance of digitally connecting production and quality systems in the adoption of next-gen predictive analytic

tools like AI and MLSimon Li, Business Development Executive, MasterControl, Taiwan

11.45 Pharmaceutical Water Systems• Cost effective WFI generation by Vapor Compression Distillation• Vapor Compression Vs Traditional Multi Effect DistillationDr. Louis Hon, Technical Sales Manager, MECO Water Purification Pte Ltd, Singapore

12.00 Merging Laboratory and Manufacturing DataThis presentation will give an introduction to digital sensor technologies and resulting benefits and capabilities. The merging of laboratory and manufacturing data is shown based on a practical example.Dr Michael Weiss, Product Management, Endress+Hauser Conducta GmbH+Co. KG, Germany

12.15 Q&A Session with speakers

WWW.ISPESINGAPORE.ORG

“The ISPE conference is an excellent way to get energised

to deliver value to my organization. I feel confident in

the implementation of concepts I learnt here.”

Catherine Le Denmat, Associate Engineer, MSD

12:30 Symposium Ends

10.00 Reserved Session for STERIS

10.15 Q&A Session with speakers

processesµ

Scott Patterson, Vice President Pharma / BioPharma Technical Support, ILC Dover, USA• CapEx and OpEx cost savings when using single use products

WWW.ISPESINGAPORE.ORG

ONSITE NETWORKINGFRIDAY, 11 DECEMBER 2020

1:30PM – 2:30PM

FRIDAY, 11 DECEMBER 2020 6:00PM – 7:00PM

Paulaner Bräuhaus Singapore

SATURDAY, 12 DECEMBER 2020 2:00PM – 5:00PM

ACCESS ONSITE & ONLINE POST-CONFERENCE WORKSHOP:PLANNING & EXECUTING A SUCCESSFUL PROJECT• Definition of a successful project

• Elements of a successful project

+ Project Charter

+ Team Structure

+ Project Planning

+ Execution Stage

+ Project Close Out

• Project Management challenges in the pharmaceutical industry

Joint Presenters:Hazem Eleskandarani, Project Director, Engineering & Property Services, Johnson & Johnson, USA Morgan O’Brien, Business Development Manager, No deviation Pte Ltd, Singapore

WOMEN IN PHARMA (WIP) ROUNDTABLE LUNCHWear your Women in Pharma pin for entry OR by S$15 minimum donation to Women in Pharma Foundation. Available at registration, ISPE and CAI stands.

Engage with inspiring women leaders in this interactive lunch discussion facilitated by our affiliate’s Women in pharma committee!

All are welcome, pre-register or join on-site subject to seat availability.

YOUNG PROFESSIONALS (YP) NETWORKINGAll are welcome to join this informal gathering, after our annual conference winds down. Whether you’re a young or seasoned professional, this is a great opportunity to engage with friends and peers over an ice cold beer.

Show your ISPE entry pass and the first drink is on us!

WWW.ISPESINGAPORE.ORG

Dear industry colleagues,

COVID-19 has shaken up industry operations as pharmaceutical manufacturing leaders are rallying to accelerate processes to bring about key medicines across borders. As the industry transforms at rigorous speed; learning developments for technical and commercial best practices are being continually refined in all aspects of manufacturing.

ISPE Singapore Affiliate’s annual conference is pleased to once again offer you a learning and networking opportunity like no other in Singapore. The 2020 edition will be both physical and virtual.

You will experience a high-quality live stream of the physical event, that promises all the content as well as virtual networking options. In addition, digital content will be available to you pre-conference, during the event and on-demand content is available up to 3 months after the conference.

2019 attracted a record 1000+ participants, the ISPE Singapore Conference and Exhibition broke new ground in 2019. We saw a strong presence of Pharma and Manufacturers, supported in an equal measure by Regulators, EPCM, and various other stakeholders and service providers. We hope to see more participation as a hybrid conference format opens more opportunities for the global community to log on and learn.

As above, industry support by itself is our testament to the quality, and we promise an even better, newer, and value-packed event experience for your benefit.

Do make the time to come with your teams. I am confident it will generate great learning value for your organisation.

I look forward to meeting you in December, online & onsite.

With regards,

Pierre Winnepenninckx Chair ISPE Singapore Conference 2020

Available

Sold

Reserved

BrukerMorimatsu

405Waldner

KingspanSilver Bullets

401

HPC306

321CAI

MTGValgenesis

MECOBarrington

James1 Supplier

503501

LinknetKneat

217

BurkertPSC

WiselyGlobalISPE

TAC

IL Dover

KCC

E&H

611

Mastercontrol

610

601603

605

623617

615619621

No DeviationSCIMED

ZenthTechnologies

Exyte

Aceplas

GEMU

Merck

Esco Healthcare

RegistrationMain Entranceto Exhibit Hall

ConferenceRooms

Available

Sold

Reserved

BrukerMorimatsu

405Waldner

KingspanSilver Bullets

401

HPC306

321CAI

MTGValgenesis

MECOBarrington

James1 Supplier

503501

LinknetKneat

217

BurkertPSC

WiselyGlobalISPE

TAC

IL Dover

KCC

E&H

611

Mastercontrol

610

601603

605

623617

615619621

No DeviationSCIMED

ZenthTechnologies

Exyte

Aceplas

GEMU

Merck

Esco Healthcare

RegistrationMain Entranceto Exhibit Hall

ConferenceRooms

WWW.ISPESINGAPORE.ORG

OUR MARKETING OUTREACH!

10,000+Contacts

Email Outreach

75,791LinkedIn

Impressions

12,438Unique Website Visitors from 112

Countries

MAKE AN INVESTMENT INTO YOUR COMPANY’S FUTURE WITH OUR SPONSORSHIP AND EXHIBITION PACKAGES

To discuss opportunities for raising your brand profile Contact: Yvonne Leong

T: +65 6508 2489 E: yvonne.leong@informa.com

Sponsorship OpportunitiesSponsoring a part of the ISPE Singapore Conference & Exhibition allows companies to target key decision makers in the international pharma manufacturing industry.

• Create company exposure • Strengthen your brand position • Reinforce relationships • Raise your profile before, during and after the event

25+Trade Media and Industry Association

Partners

RESERVE YOUR BOOTH

NOW!

P46412

10 - 12 December 2020 Suntec Singapore & Online

Optional Pre-Conference Workshop: $299

ISPE Member – Please provide ISPE membership ID during registration

FEE PER DELEGATEEarly Bird Rate Register & pay before 31 October 2020

Normal Rate Register & pay after 31 October 2020

Group Rate (per person, 3 or more delegates)

1 Day Pass $300 $400 $300

2 Day Pass $600 $700 $600

Non ISPE Member BECOME A MEMBER

FEE PER DELEGATE (SGD)Early Bird Rate Register & pay before 31 October 2020

Normal Rate Register & pay after 31 October 2020

Group Rate (per person, 3 or more delegates)

1 Day Pass $450 $550 $450

2 Day Pass $750 $850 $750

Government, Academic & Emerging Markets Rate

1 Day Pass $200

2 Day Pass $300

Special Group Rates for Pharma Companies

2 Day Pass $500

VIRTUAL EXPERIENCE

ISPE Member – Please provide ISPE membership ID during registration

FEE PER DELEGATEEarly Bird Rate Register & pay before 31 October 2020

Normal Rate Register & pay after 31 October 2020

Group Rate (per person, 3 or more delegates)

1 Day Pass $599 $799 $599

2 Day Pass $1199 $1399 $1199

Non ISPE Member BECOME A MEMBER

FEE PER DELEGATE (SGD)Early Bird Rate Register & pay before 31 October 2020

Normal Rate Register & pay after 31 October 2020

Group Rate (per person, 3 or more delegates)

1 Day Pass $899 $1499 $899

2 Day Pass $1099 $1699 $1499

Government, Academic & Emerging Markets Rate

1 Day Pass $399

2 Day Pass $599

Special Group Rates for Pharma Companies

2 Day Pass $999

PHYSICAL ONSITE EXPERIENCE

3 EASY WAYS TO REGISTERContact Miki Kong+65 6508 2477

Registration Enquiry Emailregister@informa.com

Websitewww.ispesingapore.org

Venue InformationSuntec, Singapore International Convention & Exhibition Centre 1 Raffles Boulevard Suntec City, Singapore 039593

Hotel InformationPan Pacific Singapore7 Raffles Boulevard Marina Square, SingaporeContact Person:Melissa UbanaAssistant Director of Sales - MICET: +65 6334 4952E: melissa.ubana@panpacific.com

1. For cancellation/substitution terms & conditions, please visit: https://www.informaconnect.com.sg/terms/

2. Informa Connect is a trading name of IBC Asia Pte Ltd Informa Connect

CONFERENCE AND EXHIBITION